Jade Biosciences, Inc. Common Stock
JBIOJade Biosciences, Inc. (JBIO) is a biotechnology company focused on developing innovative solutions in the fields of cell therapy and regenerative medicine. The company leverages advanced biotechnologies to create therapeutic products aimed at improving patient outcomes in various medical conditions. Through research and development, Jade Biosciences seeks to advance treatment options by combining scientific innovation with clinical applications.
$12.51 +0.51 (4.25%)
Company News
Jade Biosciences to Participate in Upcoming Conferences
Jade Biosciences, a clinical-stage biotechnology company, announced participation in multiple healthcare conferences in November 2025 and provided updates on its autoimmune disease therapy pipeline, including JADE101 and JADE201.
